|
|
Article: Research reports from Sleep Disorders Center provide new insights into sleep disorders.
- Article from:
- Biotech Week
- Article date:
- December 10, 2008
CopyrightCOPYRIGHT 2008 NewsRX. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
According to recent research published in the Journal of Clinical Psychiatry, "Evaluate efficacy and safety of the histamine-H, antagonist doxepin at doses of 1mg, 3 mg, and 6 mg in elderly adults with primary insomnia, Design: A randomized, double-blind, placebo-controlled. crossover design Was used in this population of elderly adults with primary insomnia (DSM-IV). Each treatment period consisted of 2 polysomnouraphic (PSG) assessment nights with a 5- or 12-day drug-free interval between periods."
"The study was conducted from September 2004 to January 2005. Sleep laboratories in 11 sleep centers in the United States. Elderly adults with primary insomnia. ...